Loading...
XNAS
SSKN
Market cap0kUSD
Jul 09, Last price  
0.00USD
1D
-100.00%
1Q
-100.00%
Jan 2017
-100.00%
IPO
-100.00%
Name

STRATA Skin Sciences Inc

Chart & Performance

D1W1MN
XNAS:SSKN chart
P/E
P/S
0.00
EPS
Div Yield, %
Shrs. gr., 5y
6.71%
Rev. gr., 5y
5.86%
Revenues
31m
-8.54%
000000278,461536,000915,00018,495,00031,757,00031,449,00029,855,00031,586,00023,090,00029,977,00036,161,00033,358,00033,562,00030,696,000
Net income
-6m
L-37.92%
-10,591,477-11,937,444-17,605,031-18,452,844-19,922,515-20,384,715-22,673,000-25,948,000-16,032,000-27,909,000-3,335,000-21,514,000-4,033,000-3,790,000-4,412,000-2,706,000-5,549,000-10,830,000-10,086,000-6,261,000
CFO
-3m
L
-10,141,345-11,048,937-16,204,517-17,302,714-18,820,489-17,457,861-19,223,676-19,413,000-17,709,000-6,585,000322,0004,140,0002,896,0002,229,0002,096,0001,508,000-1,108,000-519,000188,000-2,794,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

STRATA Skin Sciences, Inc. is an innovative medical technology enterprise dedicated to the development, commercialization, and marketing of advanced products specifically designed for treating a range of dermatologic conditions. The company operates through two main divisions: Dermatology Recurring Procedures and Dermatology Procedures Equipment. With a substantial global footprint, STRATA Skin Sciences distributes its solutions across the United States, Europe, the Middle East, Asia, Australia, South Africa, and both Central and South America. Its notable product portfolio includes the XTRAC and Pharos excimer laser systems, VTRAC lamp systems, and TheraClear treatment solutions. These technologies are instrumental in addressing common skin ailments such as psoriasis, vitiligo, and acne, among others. Domestically, the company engages directly with physicians for product distribution, while leveraging a network of international distributors to reach markets beyond the U.S. Established in 1989 and headquartered in Horsham, Pennsylvania, the company adopted its current name, STRATA Skin Sciences, Inc., in January 2016, having previously operated as MELA Sciences, Inc.
IPO date
Oct 28, 2005
Employees
114
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT